House Mulls Controversial FDA Mission Change
Despite warnings from the U.S. Food and Drug Administration and the pharmaceutical industry not to add controversial measures to critical user fee legislation, the House is still considering major changes to...To view the full article, register now.
Already a subscriber? Click here to view full article